📍 1 Triton Square, London NW1 3BF
Artificial Intelligence is rapidly transforming how science is conducted, from hypothesis generation and simulation to drug discovery and materials design.
This evening will bring together leading AI-for-Science startups, researchers, and investors to explore how the field is evolving from early-stage experimentation to venture-backed scale.
Through a curated innovation showcase and two focused panels, we will examine what it takes to build credible, technically rigorous, and commercially viable AI-for-Science companies in today’s funding environment.
Powered by Advanced Research + Invention Agency
In Partnership with
Supported by
Our Thursday Gatherings are for you to make serendipitous connections and make things happen!
There will be meaningful networking opportunities throughout the night, accompanied by a selection of refreshments and activities:
Fun Zone
Get to know your fellow change-makers in a fun, interactive, and exciting way!
Take a quick break from changing the world and recharge by pinning your hometown on our giant map.
Conversation Corner
Looking to connect beyond the name tags?
Drop into our relaxed Conversation Corner, a cosy space where founders, ecosystem builders, and global thinkers come together to share stories, swap lessons, and innovate. Grab a drink, pull up a chair, and jump into the discussion.
We're excited to welcome an incredible lineup of startups:
Introduction from Venture Café London.
What are the next big ideas that are going to change the world?
What’s taking off? And where will it take us?
Tonya Frolov, PhD, is a scientist–strategist and angel investor who works with biotech founders to translate complex science into clear positioning that supports fundraising, partnerships, and growth. With experience spanning research, business development, strategic communications, and fundraising—including roles at bit.bio and LabGenius—she advises venture-backed biotechs on strategy, investor narrative, and positioning, and co-founded Curated Bio, an invite-only AI × Bio dinner series that connects founders, investors, and pharma.
📍 1 Triton Square, London NW1 3BF
Artificial Intelligence is rapidly transforming how science is conducted, from hypothesis generation and simulation to drug discovery and materials design.
This evening will bring together leading AI-for-Science startups, researchers, and investors to explore how the field is evolving from early-stage experimentation to venture-backed scale.
Through a curated innovation showcase and two focused panels, we will examine what it takes to build credible, technically rigorous, and commercially viable AI-for-Science companies in today’s funding environment.
Powered by Advanced Research + Invention Agency
In Partnership with
Supported by
Our Thursday Gatherings are for you to make serendipitous connections and make things happen!
There will be meaningful networking opportunities throughout the night, accompanied by a selection of refreshments and activities:
Fun Zone
Get to know your fellow change-makers in a fun, interactive, and exciting way!
Take a quick break from changing the world and recharge by pinning your hometown on our giant map.
Conversation Corner
Looking to connect beyond the name tags?
Drop into our relaxed Conversation Corner, a cosy space where founders, ecosystem builders, and global thinkers come together to share stories, swap lessons, and innovate. Grab a drink, pull up a chair, and jump into the discussion.
We're excited to welcome an incredible lineup of startups:
Introduction from Venture Café London.
What are the next big ideas that are going to change the world?
What’s taking off? And where will it take us?
Tonya Frolov, PhD, is a scientist–strategist and angel investor who works with biotech founders to translate complex science into clear positioning that supports fundraising, partnerships, and growth. With experience spanning research, business development, strategic communications, and fundraising—including roles at bit.bio and LabGenius—she advises venture-backed biotechs on strategy, investor narrative, and positioning, and co-founded Curated Bio, an invite-only AI × Bio dinner series that connects founders, investors, and pharma.